CANDICE HESTER: Open Payments
NPI 1043784820 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,138 in 43 payments from 11 companies in 2025. Trend: 2023 $1,054 · 2024 $1,105 · 2025 $2,138
Food & beverage: $1,216Travel & lodging: $922
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $1,156 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 18 | $345 |
| Novo Nordisk Inc | 5 | $195 |
| Endologix LLC | 2 | $173 |
| Boston Scientific Corporation | 1 | $124 |
| Amgen Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: CARDIOMEMS, LifeVest, ENDOCROSS Device, ENROUTE Transcarotid Neuroprotection System, Ozempic, ESPRIT, XACT, Wegovy.
Industry payments across OK — which companies pay providers there.
